Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

147 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dissecting Clonal Heterogeneity in AML.
Schuringa JJ, Bonifer C. Schuringa JJ, et al. Cancer Cell. 2020 Dec 14;38(6):782-784. doi: 10.1016/j.ccell.2020.11.011. Cancer Cell. 2020. PMID: 33321087 Free article.
Treatment strategies in acute myeloid leukemia.
Han LN, Zhou J, Schuringa JJ, Vellenga E. Han LN, et al. Among authors: schuringa jj. Chin Med J (Engl). 2011 May;124(9):1409-21. Chin Med J (Engl). 2011. PMID: 21740756 Review.
Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML.
de Jonge HJ, Woolthuis CM, Vos AZ, Mulder A, van den Berg E, Kluin PM, van der Weide K, de Bont ES, Huls G, Vellenga E, Schuringa JJ. de Jonge HJ, et al. Among authors: schuringa jj. Leukemia. 2011 Dec;25(12):1825-33. doi: 10.1038/leu.2011.172. Epub 2011 Jul 15. Leukemia. 2011. PMID: 21760593 Clinical Trial.
Prospective Isolation and Characterization of Genetically and Functionally Distinct AML Subclones.
de Boer B, Prick J, Pruis MG, Keane P, Imperato MR, Jaques J, Brouwers-Vos AZ, Hogeling SM, Woolthuis CM, Nijk MT, Diepstra A, Wandinger S, Versele M, Attar RM, Cockerill PN, Huls G, Vellenga E, Mulder AB, Bonifer C, Schuringa JJ. de Boer B, et al. Among authors: schuringa jj. Cancer Cell. 2018 Oct 8;34(4):674-689.e8. doi: 10.1016/j.ccell.2018.08.014. Epub 2018 Sep 20. Cancer Cell. 2018. PMID: 30245083 Free article.
Pretransplantation MRD in Older Patients With AML After Treatment With Decitabine or Conventional Chemotherapy.
Hilberink JR, Morsink LM, van der Velden WJFM, Mulder AB, Hazenberg CLE, de Groot M, Choi G, Schuringa JJ, Meijer K, Blijlevens NMA, Ammatuna E, Huls G. Hilberink JR, et al. Among authors: schuringa jj. Transplant Cell Ther. 2021 Mar;27(3):246-252. doi: 10.1016/j.jtct.2020.12.014. Epub 2020 Dec 17. Transplant Cell Ther. 2021. PMID: 33781523 Free article.
The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy.
Lima K, Pereira-Martins DA, de Miranda LBL, Coelho-Silva JL, Leandro GDS, Weinhäuser I, Cavaglieri RC, Leal AM, da Silva WF, Lange APAL, Velloso EDRP, Griessinger E, Hilberink JR, Ammatuna E, Huls G, Schuringa JJ, Rego EM, Machado-Neto JA. Lima K, et al. Among authors: schuringa jj. Blood Cancer J. 2022 Nov 9;12(11):151. doi: 10.1038/s41408-022-00747-w. Blood Cancer J. 2022. PMID: 36347832 Free PMC article.
147 results